This Monday January 11, 2021 Russia announced they will propose a “light” version of their coronavirus vaccine, Sputnik V, to enable countries the most hit by the epidemic to vaccinate as many people as possible and enable to speed up the eradication of the virus. This “light” version of the vaccine is said to only require one dose (instead of the two doses in the “standard” version), protecting people vaccinated up to 85% in some cases, and even less, instead of the 90% announced for the classic version.
When it comes to financing, it is the Russian Direct Investment Fund (RDIF) that financed the development of Sputnik V that currently covers the “costs of the Sputnik-Light trial” Kirill Dmitriev, Head of the RDIF, says in a release. Sputnik V “can serve as an effective temporary solution for many countries, which are experiencing a peak of coronavirus infection” he went on. Yet, in Russia, the two-dose Sputnik V vaccine remains the main vaccine used as part of the current vaccine campaign launched in December, BFMTV explains.
For the record, Sputnik V vaccination started on December 5 in Russia, while the campaign was first set to start in January. Doctors, medical staff, social staff and teachers were the first people to be vaccinated, as they are more often exposed to the disease. As for the second dose, it will be given 21 days after the first one.
Unlike France, it has been decided not to inoculate the vaccine to people aged 60+. Are also excluded people with some health issues, pregnant women, and people who have had respiratory affection over the past two weeks.
A vaccine that has been polemical for months. Announced with great pump by Vladimir Putin, said to be 95% effective according to preliminary results, scientists said they were worried about the rapidity of authorization for issuance, as studies were still being carried out.